Emergency percutaneous coronary interventions for acute myocardial infarction with ST-segment elevation in a regional

Christophe Sierro1, Alexandre Berger, Eric Eeckhout

  • 1Unit of Cardiology, Regional Hospital (CHCV), Sion, Switzerland. Christophe.Sierro@chuv.ch

Insights

Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is safe in regional hospitals. Adherence to international guidelines ensures comparable outcomes to university centers for STEMI patients receiving emergency angioplasty.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Management

Background:

  • Primary percutaneous coronary intervention (PCI) is the leading revascularization strategy for ST-segment elevation myocardial infarction (STEMI).
  • Tertiary hospitals provide 24/7 PCI, but its feasibility in regional centers is less understood.
  • This study compares short-term outcomes of primary PCI for STEMI in a regional versus a university hospital.

Purpose of the Study:

  • To evaluate the safety and efficacy of primary PCI for STEMI in a regional hospital.
  • To compare short-term outcomes of STEMI patients treated with primary PCI in a regional institution versus a university hospital.
  • To determine if a regional hospital can achieve outcomes comparable to a university hospital when performing emergency angioplasty.

Main Methods:

  • Retrospective analysis of consecutive STEMI patients undergoing emergency coronary arteriography from January to December 2002.
  • Inclusion of patients from a regional hospital (CHCV, Sion) and a university hospital (CHUV, Lausanne).
  • Primary endpoint: combined incidence of in-hospital death, reinfarction, and target vessel revascularization (TVR) at 7 days.

Main Results:

  • The study included 58 patients at CHCV and 160 at CHUV, with similar baseline characteristics except for a higher smoking rate in CHCV.
  • Both centers predominantly used PCI (80% CHCV, 86% CHUV) with low rates of urgent surgical treatment.
  • No statistically significant difference in 7-day adverse event-free survival was observed between the two centers.

Conclusions:

  • The CHCV meets international guidelines for emergency angioplasty, enabling safe primary PCI for STEMI.
  • Around-the-clock primary PCI can be safely performed in regional hospitals like CHCV Sion.
  • Strict adherence to international guidelines is crucial for achieving comparable outcomes in regional settings.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...